Exponent, Inc.

NASDAQ:EXPO

Consulting Services

Industrials
$87.69 -0.44%

-$0.25 today

Market cap
$4.17B
Beta
0.73
P/E (TTM)
25.9
EPS (TTM)
$2.19
Dividend yield
2.15%
52W Low $51.91High $81.95

Volume 0.40M

Average 0.60M

EXPO Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Exponent, Inc.NASDAQ: EXPO

Research & Development · Q3 FY2026 · quarter ended Oct 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterOct 2026
$0— QoQ
Last fiscal yearJan 2026
$0— YoY
LTMOct 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How EXPO compares with its peers on the latest reported figures

  • EXPO's LTM Oct 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
  • Research & development amounts to 0.0% of revenue for EXPO, versus a peer median of 0.0%.
EXPO Competitors Peer median
Research & Development for EXPO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXPOExponent, Inc.LTM Oct 2026$0 ——0.0%
TTEKTetra Tech, Inc.LTM Sep 2026$0 ——0.0%
FLRFluor CorporationLTM Sep 2026$0 ——0.0%
FCNFTI Consulting, Inc.LTM Jun 2026$0 ——0.0%
KBRKBR, Inc.LTM Oct 2026$0 ——0.0%
MYRGMYR Group Inc.LTM Jun 2026$0 ——0.0%
LGNLegence Corp. Class A Common stockLTM Sep 2026$0 ——0.0%
HURNHuron Consulting Group Inc.LTM Sep 2026$0 -100.0%—0.0%
ICFIICF International, Inc.LTM Mar 2026$0 ——0.0%
CRAICRA International, Inc.LTM Apr 2026$0 ——0.0%
WLDNWilldan Group, Inc.LTM Apr 2026$0 ——0.0%
Peer median (excluding EXPO) $0-100.0%—0.0%

Competitors are the stored peer set for EXPO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Jan 2025
FY2025
Jan 2026
Revenue466.27M513.29M536.77M558.51M582.01M
Cost of Revenue342.06M348.79M401M416.23M436.71M
Gross Profit124.21M164.5M135.76M142.28M145.31M
Gross Margin26.6%32.0%25.3%25.5%25.0%
Research & Development00000
Selling, General & Admin293.33M287.9M24.44M22.73M25.52M
Operating Expenses15.28M23.66M24.44M22.73M25.52M
Depreciation & Amortization6.49M7.08M8.92M9.69M10.08M
EBITDA132.32M139.31M144.81M157.06M157.38M
EBITDA Margin28.4%27.1%27.0%28.1%27.0%
Operating Income108.93M140.84M111.32M119.56M119.79M
Operating Margin23.4%27.4%20.7%21.4%20.6%
Interest Income66K2.1M7.15M10M9.31M
Interest Expense00000
Other Income / Expenses16.91M(8.61M)24.57M27.81M27.51M
Income Before Tax125.84M132.23M135.9M147.37M147.3M
Pre-Tax Margin27.0%25.8%25.3%26.4%25.3%
Income Tax Expense24.64M29.9M35.56M38.37M41.29M
Net Income101.2M102.33M100.34M109M106.01M
Net Margin21.7%19.9%18.7%19.5%18.2%
EPS (Basic)1.921.981.962.132.08
EPS (Diluted)1.901.961.942.112.07
Weighted Avg Shares52.61M51.73M51.15M51.13M50.9M
Weighted Avg Shares (Diluted)53.33M52.28M51.64M51.57M51.24M

Exponent, Inc.

NASDAQ:EXPO

Intrinsic Alpha fair value

Locked

Current Price

$87.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.